About: covid:f04dbab83bd2a6f8cbf16ce7968ca37fbb267415

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: covid:f04dbab83bd2a6f8cbf16ce7968ca37fbb267415 Goto Sponge NotDistinct Permalink

An Entity of Type : owl:Thing, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
Creator	Mesecar, Andrew Abuhammad, Areej Brandon, \| Abuhammad, Mutasem Al-Aqtash, A Anson, J Correspondence, Areej Mutasem, \| Rua', \| Taha, Taha, O
is schema:about of	named entity 'antivirals' named entity 'virus' named entity 'emerging' named entity 'coronavirus' named entity 'tool' named entity 'Middle East respiratory syndrome coronavirus' named entity 'emerging virus' named entity 'coronavirus' named entity 'MERS' named entity 'peptide' named entity 'enzyme inhibition' named entity 'pharmacokinetic' named entity 'protein structure' named entity 'randomly selected' named entity 'homology' named entity 'binding site' named entity 'Hypo' named entity 'pharmacophore' named entity 'simulated annealing' named entity 'virus replication' named entity 'PDB' named entity 'coronavirus' named entity 'Hypo' named entity 'QSAR' named entity 'influenza' named entity 'MERS-CoV' named entity 'mass spectroscopy' named entity 'MERS-CoV' named entity 'MERS-CoV' named entity 'MCC' named entity 'drug target' named entity 'pharmacophore' named entity 'Hypo' named entity 'nuclear magnetic resonance' named entity 'Middle East respiratory syndrome coronavirus' named entity 'proteinase' named entity 'predictive validity' named entity 'Discovery Studio' named entity 'pharmacophore' named entity 'dromedary camels' named entity 'MERS-CoV' named entity 'cell-based' named entity 'MERS-CoV' named entity 'MERS-CoV' named entity 'centrifugation' named entity 'viral life cycle' named entity 'protease' named entity 'inhibitory activity' named entity 'coronaviruses' named entity 'neuraminidase inhibitor' named entity 'enzyme inhibition' named entity 'stereochemistries' named entity 'MERS-CoV' named entity 'QSAR' named entity 'QSAR' named entity 'Discovery Studio' named entity 'enzyme inhibitors' named entity 'zanamivir' named entity 'alkyl halides' named entity 'MERS-CoV' named entity 'pharmacophore' named entity 'MERS-CoV' named entity 'severe acute respiratory syndrome coronavirus' named entity 'severe pneumonia' named entity 'HKU5' named entity 'Hypo' named entity 'Escherichia coli' named entity 'QSAR' named entity 'Sequence alignment' named entity 'mortality rates' named entity 'cation-exchange chromatography' named entity 'protein' named entity 'Accelrys' named entity 'MERS-CoV' named entity 'binding site' named entity 'MERS-CoV' named entity 'Matthews correlation coefficient' named entity 'HCoV-EMC' named entity 'enzyme' named entity 'pharmacophore' named entity 'small molecule' named entity 'MERS-CoV' named entity 'carbonyl' named entity 'MERS-CoV' named entity 'protein' named entity 'mass spectroscopy' named entity 'homologous' named entity 'enzyme' named entity 'DTT'

Attributes

Values

Creator

Mesecar, Andrew
Abuhammad, Areej
Brandon, |
Abuhammad, Mutasem
Al-Aqtash, A
Anson, J
Correspondence, Areej
Mutasem, |
Rua', |
Taha,
Taha, O

is schema:about of

named entity 'antivirals'
named entity 'virus'
named entity 'emerging'
named entity 'coronavirus'
named entity 'tool'
named entity 'Middle East respiratory syndrome coronavirus'
named entity 'emerging virus'
named entity 'coronavirus'
named entity 'MERS'
named entity 'peptide'
named entity 'enzyme inhibition'
named entity 'pharmacokinetic'
named entity 'protein structure'
named entity 'randomly selected'
named entity 'homology'
named entity 'binding site'
named entity 'Hypo'
named entity 'pharmacophore'
named entity 'simulated annealing'
named entity 'virus replication'
named entity 'PDB'
named entity 'coronavirus'
named entity 'Hypo'
named entity 'QSAR'
named entity 'influenza'
named entity 'MERS-CoV'
named entity 'mass spectroscopy'
named entity 'MERS-CoV'
named entity 'MERS-CoV'
named entity 'MCC'
named entity 'drug target'
named entity 'pharmacophore'
named entity 'Hypo'
named entity 'nuclear magnetic resonance'
named entity 'Middle East respiratory syndrome coronavirus'
named entity 'proteinase'
named entity 'predictive validity'
named entity 'Discovery Studio'
named entity 'pharmacophore'
named entity 'dromedary camels'
named entity 'MERS-CoV'
named entity 'cell-based'
named entity 'MERS-CoV'
named entity 'MERS-CoV'
named entity 'centrifugation'
named entity 'viral life cycle'
named entity 'protease'
named entity 'inhibitory activity'
named entity 'coronaviruses'
named entity 'neuraminidase inhibitor'
named entity 'enzyme inhibition'
named entity 'stereochemistries'
named entity 'MERS-CoV'
named entity 'QSAR'
named entity 'QSAR'
named entity 'Discovery Studio'
named entity 'enzyme inhibitors'
named entity 'zanamivir'
named entity 'alkyl halides'
named entity 'MERS-CoV'
named entity 'pharmacophore'
named entity 'MERS-CoV'
named entity 'severe acute respiratory syndrome coronavirus'
named entity 'severe pneumonia'
named entity 'HKU5'
named entity 'Hypo'
named entity 'Escherichia coli'
named entity 'QSAR'
named entity 'Sequence alignment'
named entity 'mortality rates'
named entity 'cation-exchange chromatography'
named entity 'protein'
named entity 'Accelrys'
named entity 'MERS-CoV'
named entity 'binding site'
named entity 'MERS-CoV'
named entity 'Matthews correlation coefficient'
named entity 'HCoV-EMC'
named entity 'enzyme'
named entity 'pharmacophore'
named entity 'small molecule'
named entity 'MERS-CoV'
named entity 'carbonyl'
named entity 'MERS-CoV'
named entity 'protein'
named entity 'mass spectroscopy'
named entity 'homologous'
named entity 'enzyme'
named entity 'DTT'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software